Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

RusHydro will install electric charging stations on high-speed roads

3/28/24 HYDR

Astra reported for 2023 by RAS

3/28/24 ASTR

Magnit reported for 2023 by RAS

3/28/24 MGNT

Seligdar builds up Samolazovskoye's capacity

3/28/24 SELG

Russ-Invest IK reported for 2023 by RAS

3/28/24 RUSI

Genetiko reported for 2023 by RAS

3/28/24 GECO

Yandex presented the third generation of neural networks

3/28/24 YNDX

Rosneft's Kuibyshev refinery completely shut down

3/28/24 ROSN

Cosmos Hotel sees an increase in hotel bookings

3/28/24 AFKS

Government to purchase tablets at Aurora for ₽50 billion

3/28/24 RTKM